Literature DB >> 26839777

Pseudomonas bacteremia as an initial presentation of SLE.

Veenu Gill1, Jatinbhai Patel2, Sanjana Koshy3, Tessa Gomez2.   

Abstract

Infections have been commonly implicated in lupus relapses and in some cases as initiating the diagnostic work up of systemic lupus erythematosus (SLE). We describe here the case of a young patient who presented with Pseudomonas aeruginosa bacteremia and was found to have a new diagnosis of SLE. 53% of patients with active SLE and abdominal pain have intestinal vasculitis. These vasculitic changes can cause intestinal ischemia with consequent translocation of pathogens from the gastrointestinal tract to the bloodstream causing sepsis.

Entities:  

Keywords:  Intestinal vasculitis; Pseudomonas; SLE

Year:  2014        PMID: 26839777      PMCID: PMC4735035          DOI: 10.1016/j.idcr.2014.09.001

Source DB:  PubMed          Journal:  IDCases        ISSN: 2214-2509


Background

Infections have been commonly implicated in lupus relapses and in some cases as initiating the diagnostic work up of systemic lupus erythematosus (SLE). A previously described association in literature is that of Salmonella typhi bacteremia and Cryptococcal neoformans meningitis occurring concurrently with the first presentation of SLE [1], [2], [3]. We describe here the case of a young patient who presented with Pseudomonas aeruginosa bacteremia and was diagnosed to have SLE.

Case report

A 24 year old Chinese male was admitted to the hospital with fever with rash. Two weeks prior to presentation, patient developed subjective fevers with malaise and fatigue. He then developed a non-pruritic, non-vesicular painless rash in a centrifugal distribution. Rash started on trunk and progressed to arms, palms and face, sparing the lower extremities. He also developed painful ulcerations of oral mucosa. Associated symptoms were a cough productive of clear sputum, myalgias, constipation and 10 lb weight loss in 2 weeks. Patient denied any past medical history, sick contacts, recent hospitalization, smoking, drug use, animal contact, unprotected sexual encounter or foreign travel. Family history was non-contributory. Vital signs on admission were as follows-temperature 103.5, pulse rate 91 bpm, blood pressure 121/60 mmhg, respiratory rate 17/min, oxygen saturation 97% on room air. Physical exam showed oral mucosal ulcerations with thrush, cervical lymphadenopathy, splenomegaly, multiple discrete ‘salmon colored’ spots on chest, back, palms and arms. Initial blood tests revealed pancytopenia (Table 1). Chest X-ray did not show any infiltrates.
Table 1

Laboratory values.

ParameterReference rangeAt initial evaluationFollow up
White blood cell count, cell/mm34500–10,80026004500
Absolute neutrophil count1800–800021003800
Hemoglobin, g/dL13.5–1712.812.3
Platelets, cell/mm3150,000–450,00055,000172,000
Erythrocyte sedimentation rate, mm/h0–301415
C reactive protein, mg/dl0–1<0.50.7
Ferritin, ng/ml22–32210,2623355
Creatinine kinase, units/L55–17010,8871299
Aspartate transaminase, units/L15–4681219
Alanine transaminase, units/L13–6951124
Alkaline phosphatase, units/L38–12610757
Total bilirubin, mg/dL0.2–1.30.80.3
ANA1:160
Rheumatoid factor, IU/ml<11<11
Anti Smith antibody, EU/ml<1625
ds DNA, IU/ml0–29>300>300
Sjogren Ab, EU/ml<16156
SM – RNP Ab, EU/ml<1680
Complement – C3, mg/dL88–2012143
Complement – C4, mg/dL16–4757
Initial presentation suggested a mononucleosis-like syndrome hence serologies for EBV, HIV, CMV, Coxsackie, Rubella, Measles were drawn that later returned no diagnostic. Blood culture on admission was positive for P. aeruginosa sensitive to cefepime, gentamicin, imipenem and ciprofloxacin. He was started on intravenous cefepime. Despite appropriate antibiotics, patient remained febrile and gentamicin was added to the regimen. An abdominal ultrasound done for elevated liver enzymes revealed splenomegaly. Due to multi-system involvement, an autoimmune etiology was suspected. Corresponding workup found (Table 1) ANA positive at 1:160, positive anti-DS DNA and anti-SM and hypocomplementemia with C3 21 and C4 5. Given these laboratory tests consistent with the diagnosis of SLE, patient was started on steroids and hydroxychloroquine. Over the next few days, patient improved clinically with resolution of fevers, fatigue, and malaise. His oral ulcers were healing and he was able to tolerate oral feedings. Liver function abnormalities improved from those at admission. Repeat blood cultures were negative. Patient was discharged on intravenous antimicrobials to complete treatment in addition to prednisone and hydroxychloroquine.

Discussion

SLE is a chronic inflammatory multisystem disease with immunological abnormalities and seen more often in women than men. There is a known association between immunosuppression caused by medications used to treat SLE and the increased propensity of infections [5]. There have been few cases described of Salmonella enterica serotype typhi bacteremia as initial presentation of SLE in patients not on immunomodulators [3]. P. aeruginosa is frequently encountered in nosocomial infections especially in immunocompromised patients. P. aeruginosa bacteremia can be traced back to several sources including but not limited to contaminated water, gastrointestinal tract, lungs and indwelling catheters [6]. 53% of patients with active SLE and abdominal pain have intestinal vasculitis. A negative abdominal examination does not rule out disease as SLE involves small vessels [4]. These vasculitic changes can cause intestinal ischemia with consequent translocation of pathogens from the gastrointestinal tract to the bloodstream causing sepsis.
  6 in total

Review 1.  A review of gastrointestinal manifestations of systemic lupus erythematosus.

Authors:  S M Sultan; Y Ioannou; D A Isenberg
Journal:  Rheumatology (Oxford)       Date:  1999-10       Impact factor: 7.580

2.  Risk factors and a clinical index for diagnosis of Pseudomonas aeruginosa bacteremia.

Authors:  William R. Gransden; Leonard Leibovici; Susannah J. Eykyn; Silvio D. Pitlik; Zmira Samra; Hanna Konisberger; Moshe Drucker; Ian Phillips
Journal:  Clin Microbiol Infect       Date:  1995-02       Impact factor: 8.067

3.  Cryptococcal meningitis presenting concurrently with systemic lupus erythematosus.

Authors:  C C Mok; C S Lau; K Y Yuen
Journal:  Clin Exp Rheumatol       Date:  1998 Mar-Apr       Impact factor: 4.473

Review 4.  Infection risk in systemic lupus erythematosus patients: susceptibility factors and preventive strategies.

Authors:  A Danza; G Ruiz-Irastorza
Journal:  Lupus       Date:  2013-10       Impact factor: 2.911

5.  Salmonella bacteraemia occurring concurrently with the first presentation of systemic lupus erythematosus.

Authors:  E K Li; M G Cohen; A K Ho; A F Cheng
Journal:  Br J Rheumatol       Date:  1993-01

Review 6.  Concurrent presentation of cryptococcal meningoencephalitis and systemic lupus erythematosus.

Authors:  Masami Matsumura; Rika Kawamura; Ryo Inoue; Kazunori Yamada; Mitsuhiro Kawano; Masakazu Yamagishi
Journal:  Mod Rheumatol       Date:  2010-12-29       Impact factor: 3.023

  6 in total
  1 in total

Review 1.  [Systemic lupus erythematosus : Unusual cutaneous manifestations].

Authors:  T Stockinger; L Richter; M Kanzler; M Melichart-Kotik; H Pas; K Derfler; E Schmidt; K Rappersberger
Journal:  Hautarzt       Date:  2016-12       Impact factor: 0.751

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.